Why Cannabis Can't Get
Normal Financial Terms

Cannabis insurance solutions that actually work have to address three problems at once: banking, commercial insurance, and capital access. Cannabis operators deal with all three systems failing simultaneously. Banks lock them out. The commercial market prices them into corners and writes exclusions around their biggest exposures. And traditional lending, including Small Business Administration programs and standard lines of credit, is largely unavailable to cannabis businesses. These are not three separate problems. They are three symptoms of the same structural cause.

The structural cause is federal scheduling. Cannabis remains a Schedule I controlled substance under federal law. Every financial system that operates with federal oversight, federal insurance, federal licensing, or federal reinsurance backing has a reason to avoid cannabis. That covers most of the financial infrastructure that other businesses take for granted.

This article walks through each of the three systems, explains why they fail cannabis operators specifically, and lays out what a captive insurance company actually fixes, and what it does not.

Why Banks Won't Take Your Money

Most cannabis operators already know this problem firsthand. You walked into a bank with a legitimate, licensed business, and they turned you away. If they didn't, you paid fees that no other business pays to keep the relationship. And even then, you probably hold more cash on-site than any sensible business should.

The reason is not that banks dislike cannabis. It is that most banks are federally chartered, federally insured, or both. A federally insured bank that knowingly takes deposits from a Schedule I cannabis business is technically handling proceeds from an activity that remains a federal crime. The Financial Crimes Enforcement Network, or FinCEN, the federal bureau that oversees anti-money-laundering compliance, issued guidance in 2014 that outlined a path for banks to serve cannabis businesses while managing their own compliance exposure. The guidance did not legalize it. It just told banks what paperwork they would need to file if they tried.

Practically, that meant only credit unions and community banks with specific risk tolerances were willing to take cannabis accounts. Larger regional and national banks stayed out. The result is a market where a multi-location cannabis operator grossing $10 million a year might bank with an institution better suited for a local hardware store, paying monthly fees of $1,000 to $3,000 just for basic account access, and holding significant cash reserves on-site because their banking relationship cannot fully absorb the volume.

Cash on-site is not just an inconvenience. It is an insurance problem. Standard commercial crime and theft policies are written around normal banking relationships. A cannabis operator carrying $200,000 in cash on a Friday night because they cannot deposit it over the weekend faces a coverage gap that most commercial insurers either will not write or will cap at limits designed for a coffee shop.

The Reinsurance Problem Nobody Talks About

Most cannabis operators have heard that commercial insurance is expensive and hard to get. Fewer know exactly why. The answer is reinsurance.

Reinsurance is the insurance that insurance companies buy. When a carrier writes a policy for your business, they do not keep 100 percent of that risk. They pass a portion of it to a reinsurer, a large financial institution that absorbs risk in exchange for a share of the premium. The major global reinsurers, including Lloyd's of London syndicates, Munich Re, and Swiss Re, operate under regulatory frameworks that have largely avoided cannabis exposure. Because they are internationally active entities with regulatory exposure in multiple jurisdictions, many have policies that prohibit or sharply limit their participation in cannabis reinsurance.

When a carrier cannot reinsure a risk, they either decline to write it entirely or write it on an unreinsured basis at significantly higher prices to compensate for holding the full exposure themselves. That is the primary reason cannabis insurance premiums run two to four times higher than comparable non-cannabis businesses. It is not that the individual claims are dramatically worse. It is that the carriers writing the coverage are doing it without the safety net that makes insurance economically viable at normal pricing.

A captive insurance company changes this picture at the structural level. Because the captive is owned by the operator and writes coverage for that operator's specific risk, it does not depend on the commercial reinsurance market to function. The operator is effectively acting as their own carrier, setting premiums based on their own loss history, funding reserves from those premiums, and paying claims from those reserves. In a well-structured captive within a risk pool, the operator's captive insures a defined layer of risk. Above that layer, the pool provides backup capacity among participating members, effectively a form of mutual reinsurance that does not require commercial reinsurers to be involved.

This matters because it removes the structural bottleneck that drives commercial cannabis insurance pricing. You are no longer competing for coverage from a handful of surplus lines carriers working without reinsurance support. You are operating your own insurer, pricing against your own loss history, and keeping the difference when you run well.

Capital Access Is Broken Too

Banks will not lend to businesses they will not bank. That eliminates most conventional business lending for cannabis operators. The Small Business Administration, or SBA, explicitly excludes cannabis from its loan programs, including the 7(a) and 504 programs that most small businesses use for equipment financing, real estate, and working capital. Equipment lenders face the same federal exposure that banks do. Traditional asset-based lending typically requires that the collateral, including inventory, receivables, and equipment, be legally transferable under federal law.

What cannabis operators are left with is a narrow set of options: equity investors who demand ownership and often expect cannabis-level risk premiums, specialty cannabis lenders who charge double-digit interest rates to compensate for their own risk exposure, or self-financing from operations. A cannabis operator who wants to open a second location, add processing capacity, or weather a difficult quarter has fewer tools to do it than almost any other licensed industry in the country.

Here is a concrete example of how this plays out. A dispensary operator in a competitive market wants to open a second location. The build-out will cost $800,000. A conventional Small Business Administration 504 loan at current rates might cost $52,000 per year in debt service. The same operator going to a cannabis-specialty lender at 14 percent interest over five years pays roughly $111,000 per year for the same $800,000. Over five years that is nearly $300,000 in additional interest cost, just because of what the business does. That capital premium is a direct drag on every growth decision the business makes.

What a Captive Actually Fixes

A captive does not fix the banking problem and does not change cannabis lending markets. Let's be direct about that. What it does fix is the insurance problem at its structural root, and by doing so, it creates a capital accumulation tool that partially compensates for the lack of access elsewhere.

On the insurance side: a captive can write coverage that the commercial market will not. That includes property coverage for cannabis inventory at actual value, product recall coverage designed around the specific regulatory recall procedures in the operator's state, cash on-premises coverage at limits appropriate for a cash-intensive business, and cyber coverage without the exclusions that make standard policies unreliable after an incident. These are not policies that exist in the standard market. A captive writes them because the captive's policies are not governed by what commercial carriers are willing to offer.

On the capital side: every dollar of premium that does not result in a claim stays in the captive as surplus. In a commercial insurance program, that money belongs to the carrier. The carrier collects the premium, invests the float, pays claims from pooled reserves, and keeps the underwriting profit. When you run a well-managed operation with a good loss history, you are subsidizing the rest of the commercial pool. You are the insured the carrier actually wants, and you are the one sending them money every renewal.

In a captive, the underwriting profit stays with you. A cannabis operator paying $300,000 per year in commercial premiums across all lines, running lean operations with below-average claims, might realistically accumulate $800,000 to $1.2 million in captive surplus over five years. That is capital that doesn't come from a bank, doesn't require an equity investor, and doesn't carry a 14 percent interest rate. It accumulates from your own discipline as an operator. It belongs to you because you built a business worth insuring.

Outside investors see it too. A captive is a licensed insurance company that the operator owns. That means the captive's surplus is a real asset on the balance sheet. An equity investor doing due diligence on a cannabis acquisition or growth round will read a captive as evidence of several things at once: the operator manages risk rather than just absorbing it, the premium spend is building equity instead of disappearing to a carrier, and the business is not fully exposed to commercial insurance market disruptions that have historically blindsided cannabis operators without alternatives. In an industry where most operators look similar on paper, a captive with a documented underwriting track record is a differentiator in a due diligence conversation.

The tax treatment deserves a direct note. Section 831(b) of the Internal Revenue Code allows a qualifying small captive insurer to exclude underwriting income from taxable income. For 2026, the annual limit on that exclusion is $2.9 million. That benefit sits on the captive side. On the operator side, the picture is more complicated. For most businesses, insurance premiums are deductible as ordinary business expenses under Section 162 of the Internal Revenue Code. Currently, cannabis operators do not get that deduction. Section 280E of the Internal Revenue Code blocks deductions for businesses that traffic in Schedule I controlled substances, which includes cannabis under current federal law. Every premium dollar a cannabis operator pays goes out after tax. The 831(b) election on the captive side partially offsets that disadvantage: the underwriting income the captive earns is excluded from taxable income, which is a real benefit against the deduction you cannot take on the premium side.

The Internal Revenue Service finalized regulations in January 2025 targeting captive arrangements where the tax benefit was the entire point rather than the actual insurance function. Those arrangements are designated listed transactions and carry serious consequences. 3F builds captives around genuine risk transfer and real actuarial underwriting. The 831(b) benefit is something a well-run captive earns by doing the work, not something you manufacture by calling something insurance.

The Compounding Effect

Banking, reinsurance, and capital do not just run in parallel. They compound each other.

When the commercial insurance market hardens and your carrier raises rates or restricts coverage, you cannot easily finance your way through it. The same lenders who would help a restaurant operator absorb a premium increase with a short-term credit line are not available to you. And your banking relationship may not be stable enough to give you the cash flow flexibility you need to absorb the shock.

A cannabis operator that enters a hard market cycle without a captive structure faces the full force of that cycle on its own. Premium increases hit harder because there is no financial cushion. Coverage restrictions hit harder because there are no alternatives. And when a claim finally comes, a product recall, a theft event, or a cyber incident, the operator discovers what their policy actually covers, which is often less than what they thought. A 3F coverage review identifies exactly those gaps before a claim exposes them.

The operator with a captive is in a different position. The captive provides a stable insurance foundation that does not move with the commercial market cycle. If commercial rates spike, the captive's contribution to the overall program is unaffected. If commercial carriers exit cannabis in a particular state or line of coverage, the captive can write coverage for that gap. And the capital accumulated in the captive over prior years of good underwriting results gives the operator a financial cushion that does not depend on a bank or a lender.

Do You Qualify?

The conversation is worth having if several of these sound familiar:

‍

• You spend $50,000 or more per year on commercial insurance premiums across all lines, and you believe your actual claims record is significantly better than the pricing you receive. That $50,000 floor is 3F's cannabis-specific threshold. The general standard for most industries is $250,000. Cannabis operators often qualify economically at a lower floor because commercial pricing in this market is structurally inflated, and the captive math works at smaller premium volumes than it would for a conventional business.
• You carry cash on-premises in amounts that your current commercial crime or theft policy would not fully cover.
• You have experienced a coverage restriction, a non-renewal, or a policy exclusion that left a meaningful gap in your program.
• You are growing and cannot access the business credit that a comparable non-cannabis business would use to finance that growth.
• You want to build equity in something your insurance spend contributes to, instead of sending it to a carrier who does not share the profit.
• You have capital available to meet the captive's initial reserve and capitalization requirement. A captive is a licensed insurance company. It requires real upfront funding to operate, not just an ongoing premium commitment. The amount varies by domicile state and structure. It is a real financial commitment that needs to be part of your decision.

‍

If most of those apply, a coverage review is the right starting point. We read the policies, find the gaps, and tell you plainly whether a captive makes sense for your operation. If the math does not work yet, you leave knowing what your program actually covers.

One additional consideration for operators watching the federal rescheduling process: if cannabis moves to Schedule III, Section 280E no longer applies. The deduction block goes away. At that point, your insurance premiums become deductible as ordinary business expenses under Section 162, the same as any other industry. A captive becomes even more attractive in that scenario. You would be deducting the premiums on the way in and your captive's underwriting income would still benefit from the Section 831(b) exclusion on the other side. The structure that made sense when premiums were non-deductible becomes more favorable when they are.

Cannabis insurance solutions that actually address the structural problem are available. They require a licensed captive, proper actuarial underwriting, and a compliance-first structure. 3F Captive Services starts with a no-cost coverage review. Start at 3fcaptiveservices.com.

Sources

[1] Financial Crimes Enforcement Network (FinCEN). FIN-2014-G001: BSA Expectations Regarding Marijuana-Related Businesses. February 2014. https://www.fincen.gov

[2] U.S. Small Business Administration (SBA). Standard Operating Procedure 50 10 7.1: Cannabis businesses ineligible for SBA loan programs.

[3] National Cannabis Industry Association (NCIA). Annual Cannabis Business Survey data on insurance costs and banking access.

[4] Internal Revenue Code Section 831(b). IRS final regulations on micro-captive listed transactions, effective January 2025. 2026 annual premium limit: $2.9 million.

[5] Lloyd's of London. Underwriting guidance on cannabis risk exposure across active syndicates. Market Bulletin references.

[6] Marijuana Policy Project. State-by-state cannabis banking access data and credit union participation rates.

‍